Our vertically-integrated supply chain model provides development and manufacturing expertise spanning the complete cGMP supply chain, from regulated raw materials through intermediates, APIs, commercial-scale drug substance manufacturing, niched formulation, clinical trial, manufacturing and fill and finish, and supply chain logistics.
Quality is part of our values and we aim to assure rather than control compliance with regulatory requirements. By having a quality-based culture, there are fewer manufacturing issues and thus reduced downtime and product losses. Our 70 years of combined experience, successful audits, customer delivery, along with an excellent quality reputation, have been key to our history of winning.
If managed improperly, sourcing can result in supply chain interruptions, significant unexpected expenses and quality control issues. Our team of highly qualified sourcing experts ensure effective sourcing and building in supply safety, legal and regulatory compliance, and protecting timeliness of receiving materials to keep your project moving.
Preparing for and working with the FDA, EMA and other world regulatory bodies require a large amount of work. Insufficient documentation delays regulatory submissions and can hinder bringing a new drug to market. We build regulatory requirements into every single project, from the first day forward. Using our experience in multiple successful filings, we actively support regulatory drafting all through your project.
Malin Melander
Malin holds a Master of Science in Engineering Physics from Lund University, and has 20 years of experience from different positions within the healthcare industry. Malin joined Magle Chemoswed in 2018, reinforcing the quality and regulatory expertise within the company.